Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think
- PMID: 21948802
- PMCID: PMC3182047
- DOI: 10.1084/jem.20111855
Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think
Abstract
Notch signaling is often considered a model hematopoietic proto-oncogene because of its role as the main trigger of T cell acute lymphoblastic leukemia (T-ALL). Although its role in T-ALL is well characterized and further supported by a high frequency of activating NOTCH1 mutations in T-ALL patients, it still remains an open question whether the effects of Notch signaling are causative in other types of cancer, including solid tumors. Growing evidence supported by recent studies unexpectedly shows that Notch signaling can also have a potent tumor suppressor function in both solid tumors and hematological malignancies. We discuss the intriguing possibility that the pleiotropic functions of Notch can be tumor suppressive or oncogenic depending on the cellular context.
Similar articles
-
The opposing roles of NOTCH signalling in head and neck cancer: a mini review.Oral Dis. 2015 Oct;21(7):850-7. doi: 10.1111/odi.12309. Epub 2015 Jan 29. Oral Dis. 2015. PMID: 25580884 Review.
-
Notch signaling: switching an oncogene to a tumor suppressor.Blood. 2014 Apr 17;123(16):2451-9. doi: 10.1182/blood-2013-08-355818. Epub 2014 Mar 7. Blood. 2014. PMID: 24608975 Free PMC article. Review.
-
The Relevance of Notch Signaling in Cancer Progression.Adv Exp Med Biol. 2021;1287:169-181. doi: 10.1007/978-3-030-55031-8_11. Adv Exp Med Biol. 2021. PMID: 33034032 Review.
-
Notch signaling in leukemias and lymphomas.Curr Mol Med. 2008 Feb;8(1):51-9. doi: 10.2174/156652408783565540. Curr Mol Med. 2008. PMID: 18289013 Review.
-
The double-edged sword of Notch signaling in cancer.Semin Cell Dev Biol. 2012 Jun;23(4):458-64. doi: 10.1016/j.semcdb.2012.01.017. Epub 2012 Jan 30. Semin Cell Dev Biol. 2012. PMID: 22309843 Free PMC article. Review.
Cited by
-
Regulated proteolysis of Trop2 drives epithelial hyperplasia and stem cell self-renewal via β-catenin signaling.Genes Dev. 2012 Oct 15;26(20):2271-85. doi: 10.1101/gad.196451.112. Genes Dev. 2012. PMID: 23070813 Free PMC article.
-
Notch Signaling Pathway in Cancer-Review with Bioinformatic Analysis.Cancers (Basel). 2021 Feb 12;13(4):768. doi: 10.3390/cancers13040768. Cancers (Basel). 2021. PMID: 33673145 Free PMC article.
-
Radio-miRs: a comprehensive view of radioresistance-related microRNAs.Genetics. 2024 Aug 7;227(4):iyae097. doi: 10.1093/genetics/iyae097. Genetics. 2024. PMID: 38963803 Free PMC article. Review.
-
Gamma Secretase Inhibitors as Potential Therapeutic Targets for Notch Signaling in Uterine Leiomyosarcoma.Int J Mol Sci. 2022 May 26;23(11):5980. doi: 10.3390/ijms23115980. Int J Mol Sci. 2022. PMID: 35682660 Free PMC article.
-
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia.Cell Chem Biol. 2020 Jun 18;27(6):678-697.e13. doi: 10.1016/j.chembiol.2020.04.002. Epub 2020 May 7. Cell Chem Biol. 2020. PMID: 32386594 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA173636/CA/NCI NIH HHS/United States
- R01 CA133379/CA/NCI NIH HHS/United States
- R01CA133379/CA/NCI NIH HHS/United States
- R21CA141399/CA/NCI NIH HHS/United States
- R01 CA149655/CA/NCI NIH HHS/United States
- R01 CA105129/CA/NCI NIH HHS/United States
- HHMI/Howard Hughes Medical Institute/United States
- R21 CA141399/CA/NCI NIH HHS/United States
- R01CA149655/CA/NCI NIH HHS/United States
- R01CA105129/CA/NCI NIH HHS/United States
- R01 GM088847/GM/NIGMS NIH HHS/United States
- R01GM088847/GM/NIGMS NIH HHS/United States
- R01 CA169784/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical